@article{Stock_S-2022_51370,
title = {SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland},
author = {Stock, S. and Carruthers, J. and Calvert, C. and Denny, C. and Donaghy, J. and Goulding, A. and Hopcroft, L. and Hopkins, L. and McLaughlin, T. and Pan, J. and Shi, T. and Taylor, B. and Agrawal, U. and Auyeung, B. and Katikireddi, S. and McCowan, C. and Murray, J. and Simpson, C. and Robertson, C. and Vasileiou, E. and Sheikh, A. and Wood, R.},
month = {jan},
year = {2022},
abstract = {Population-level data on COVID-19 vaccine uptake in pregnancy and SARS-CoV-2 infection outcomes are lacking. We describe COVID-19 vaccine uptake and SARS-CoV-2 infection in pregnant women in Scotland, using whole-population data from a national, prospective cohort. Between the start of a COVID-19 vaccine program in Scotland, on 8 December 2020 and 31 October 2021, 25,917 COVID-19 vaccinations were given to 18,457 pregnant women. Vaccine coverage was substantially lower in pregnant women than in the general female population of 18−44 years; 32.3% of women giving birth in October 2021 had two doses of vaccine compared to 77.4% in all women. The extended perinatal mortality rate for women who gave birth within 28 d of a COVID-19 diagnosis was 22.6 per 1,000 births (95% CI 12.9−38.5; pandemic background rate 5.6 per 1,000 births; 452 out of 80,456; 95% CI 5.1−6.2). Overall, 77.4% (3,833 out of 4,950; 95% CI 76.2−78.6) of SARS-CoV-2 infections, 90.9% (748 out of 823; 95% CI 88.7−92.7) of SARS-CoV-2 associated with hospital admission and 98% (102 out of 104; 95% CI 92.5−99.7) of SARS-CoV-2 associated with critical care admission, as well as all baby deaths, occurred in pregnant women who were unvaccinated at the time of COVID-19 diagnosis. Addressing low vaccine uptake rates in pregnant women is imperative to protect the health of women and babies in the ongoing pandemic.},
journal = {Nature Medicine},
publisher = {Springer Nature},
url = {https://doi.org/10.1038/s41591-021-01666-2},
}
